Enomoto Yukiko, Yoshimura Shinichi, Egashira Yusuke, Yamagami Hiroshi, Sakai Nobuyuki
Department of Neurosurgery, Graduate School of Medicine, Gifu University, Gifu, Japan.
Department of Neurosurgery, Hyogo Collage of Medicine, Hyogo, Japan.
J Stroke Cerebrovasc Dis. 2016 May;25(5):1076-1080. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.022. Epub 2016 Feb 26.
Recanalization therapies such as intravenous thrombolysis (IVT) or endovascular treatment (EVT) improve acute ischemic stroke outcomes; however, they carry the risk of intracranial hemorrhage (ICH). The present study assessed the frequency and predictive factor of ICH in Japanese patients with acute large vessel occlusion.
The Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism-Japan Registry prospectively registered 1442 stroke patients with major vessel occlusion who were admitted to 84 Japanese stroke centers within 24 hours after onset, from July 2010 to June 2011. Among these 1442 patients, 1357 were included to evaluate the incidence rate and predictive factors of ICH within 24 hours after onset.
ICH was observed in 284 (20.9%) patients. Among these patients, 46 (3.4%) had symptomatic ICH, and its incidence was higher in the recanalization therapy (IVT and/or EVT) group than in the conservative therapy group (4.5% versus 2.1%, P = .013). On multivariate analyses, symptomatic ICH was related to pretreatment antiplatelet agent use and systemic heparinization, and was related to neither IVT nor EVT.
Symptomatic ICH was not affected by recanalization therapy or EVT itself in Japanese patients with acute large vessel occlusion.
静脉溶栓(IVT)或血管内治疗(EVT)等再通治疗可改善急性缺血性卒中的预后;然而,它们存在颅内出血(ICH)的风险。本研究评估了日本急性大血管闭塞患者颅内出血的发生率及预测因素。
脑超急性栓塞血管内挽救恢复-日本注册研究前瞻性纳入了2010年7月至2011年6月期间在日本84个卒中中心发病24小时内入院的1442例主要血管闭塞性卒中患者。在这1442例患者中,1357例被纳入评估发病后24小时内颅内出血的发生率及预测因素。
284例(20.9%)患者发生颅内出血。其中,46例(3.4%)发生症状性颅内出血,再通治疗(IVT和/或EVT)组的发生率高于保守治疗组(4.5%对2.1%,P = 0.013)。多因素分析显示,症状性颅内出血与治疗前使用抗血小板药物及全身肝素化有关,与IVT和EVT均无关。
在日本急性大血管闭塞患者中,症状性颅内出血不受再通治疗或EVT本身的影响。